Callum Meikle
Direktor/Vorstandsmitglied bei Scottish Ballet
Profil
Callum Meikle has worked as a Director at Scottish Ballet and as a Non-Executive Director at Pleco Therapeutics BV.
Aktive Positionen von Callum Meikle
Unternehmen | Position | Beginn |
---|---|---|
Scottish Ballet
Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Scottish Ballet
Scottish Ballet Movies/EntertainmentConsumer Services Scottish Ballet operates as a dance company. The company was founded by Peter Darrell and Elizabeth West in 1957 and is headquartered in Glasgow, the United Kingdom. | Consumer Services |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Pleco Therapeutics BV is a Dutch clinical stage specialty pharmaceutical company that aims to improve the effectiveness of existing chemotherapy through its novel plecoid™ therapies. The company is based in Nijmegen, Netherlands. These therapies have the potential to positively change the balance of protein expression within the cancer microenvironment, removing the burden of toxic metals within the cell. The CEO of the company is Ivo Timmermans. | Commercial Services |